Safety and Tolerability of an Antibody Against Yellow Fever Virus (TY014) in Humans (Q62030793)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and Tolerability of an Antibody Against Yellow Fever Virus (TY014) in Humans |
clinical trial |
Statements
Phase 1 First-in-Human, Time Lagged, Single Ascending Dose Study of TY014 in Healthy Adult Volunteers (Safety Arm - 1A) and Sequential Time Lagged, Parallel-Group, Randomised, Placebo-Controlled, Double-Blind, Single Ascending Dose Study of TY014 in YF-17D Vaccine Strain-Challenged Healthy Adult Volunteers (Efficacy Arm - 1B) (English)
0 references
6 December 2018
0 references
30 June 2019
0 references
67
0 references
21 year
0 references
50 year
0 references